A live webcast will cover PetMeds' results on Nov. 10 at 4:30 p.m. ET

PetMed Express (PETS) will release its Q2 2026 financial results on Nov. 10 after market close and host a conference call at 4:30 p.m. ET. The company is a direct-to-consumer pet healthcare provider, operating online pharmacies PetMeds and PetCareRx.

Original reporting
Published Oct 27, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PETS
Neutral
medium confidence
Mentioned
$PETS
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$PETSNeutralLow
01

Why it matters

The announcement of the earnings webcast date alone offers little actionable insight; price movement will likely await the actual results.

02

Market read

Low relevance; serves as a reminder of an upcoming earnings release with no new financial metrics.

03

What to watch

Potential market anticipation of results, but no concrete data provided.

Relevance 4/10Novelty 3/10Timing: Nov 10, 2026 after market close

Background

PetMed Express (NASDAQ:PETS) is a leading online pet‑health pharmacy. The company is scheduled to release its Q2 2026 earnings on Nov 10.

Company-level read

Ticker impact

$PETSNeutralMedium confidence
Context

PetMed Express announced it will report its Q2 2026 results on Nov 10, 2026.

Expected impact

minimal impact as no guidance or results are disclosed yet

Evidence & confidence

The article only provides the timing of the earnings release; traders have no new data to act on.

Market effects

None disclosed

None disclosed

Limited to investors tracking pet‑care sector earnings

Counterpoint

No contrarian angle; the notice is purely informational.

Key entities

  • PetMed Express, Inc.

    Online pet pharmacy reporting Q2 2026 earnings

Related articles

$PETSMed

PetMed Express Inc (PETS) (Q2 2027) Earnings Call Highlights: New CEO Charts

PetMed Express (PETS) reported Q2 2027 net sales of $35.8M, down 19.4% YoY, with a net loss of $6.4M. New CEO Jeff Willard highlighted cost reductions, including a 32% drop in customer acquisition cost and a 52.3% cut in advertising expenses. The company has $11.4M in cash and no debt. Willard outlined a multiyear turnaround strategy focusing on brand repositioning, marketing efficiency, and customer retention. Gross margin fell to 27.4% due to product mix and lower rebates.

$PETSMed

PetMed Express (PETS) Q1 2027 Earnings Call Transcript

PetMed Express reported Q1 2027 net sales of $41M, down 19.9% YoY, with a net loss of $6.1M. Key highlights include a $37M sale-leaseback deal, a partnership with Rural King, and an unsolicited acquisition offer of $3 per share. Management emphasized expense management and new revenue channels. Net sales stabilized above $40M sequentially, despite prescription sales declines.

$PETSMedAI 9/10

PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navigating Challenges and Embracing...

PetMed Express (PETS) reported fiscal 2026 net sales down 21.1% and a full-year net loss of $57.3 million, including $26.7 million goodwill impairment and $2.1 million inventory write-down, plus $4.5 million in non-recurring legal/severance costs tied to a whistleblower probe. The company said it regained regulatory compliance, fixed three material weaknesses, exited underperforming vendors for ~$6.1 million annualized savings, and saw its first Q4 sequential net sales increase since 2024.

$NVDAHighAI 9/10

What's Going On With Nvidia Stock Wednesday

Nvidia (NVDA) reported quarterly earnings of $2.68 per share on revenue of $115.84 billion, beating estimates. Data center sales reached $107.6 billion. The company raised its revenue forecast for the current quarter and long-term growth outlook, but expects no revenue from China. Nvidia also expanded its stock buyback program.